WESPAC Advisors SoCal LLC Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

WESPAC Advisors SoCal LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,838 shares of the biotechnology company’s stock, valued at approximately $575,000.

A number of other institutional investors have also modified their holdings of the business. ICA Group Wealth Management LLC acquired a new position in Axon Enterprise in the 4th quarter valued at $26,000. Trivant Custom Portfolio Group LLC acquired a new position in Axon Enterprise in the 1st quarter valued at $31,000. BKM Wealth Management LLC acquired a new position in Axon Enterprise in the 4th quarter valued at $32,000. First PREMIER Bank acquired a new position in Axon Enterprise in the 1st quarter valued at $33,000. Finally, Key Financial Inc increased its stake in Axon Enterprise by 367.6% in the 4th quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock valued at $41,000 after buying an additional 125 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 308 shares of the stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the sale, the director now owns 1,607 shares of the company’s stock, valued at $498,282.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Jeri Williams sold 308 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total transaction of $95,501.56. Following the completion of the transaction, the director now directly owns 1,607 shares in the company, valued at approximately $498,282.49. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Jeffrey C. Kunins sold 43,668 shares of the stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $309.94, for a total value of $13,534,459.92. Following the transaction, the insider now owns 189,719 shares of the company’s stock, valued at $58,801,506.86. The disclosure for this sale can be found here. Insiders sold 89,447 shares of company stock valued at $27,684,677 over the last 90 days. 5.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on AXON shares. William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Craig Hallum upped their price target on shares of Axon Enterprise from $325.00 to $370.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th. JPMorgan Chase & Co. upped their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research note on Thursday, April 11th. StockNews.com cut shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $375.00 price target on shares of Axon Enterprise in a research note on Tuesday, May 7th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $335.27.

Axon Enterprise Trading Down 1.7 %

AXON traded down $5.03 on Monday, reaching $289.21. 331,741 shares of the company’s stock were exchanged, compared to its average volume of 495,688. The company’s 50 day moving average is $295.16 and its 200-day moving average is $285.51. The company has a market cap of $21.83 billion, a price-to-earnings ratio of 84.56 and a beta of 0.95. Axon Enterprise, Inc. has a twelve month low of $175.37 and a twelve month high of $329.87. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.55 and a current ratio of 2.91.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.20. The firm had revenue of $460.74 million during the quarter, compared to the consensus estimate of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The company’s revenue was up 34.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.51 EPS. Equities analysts predict that Axon Enterprise, Inc. will post 2.35 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.